| Aa-012M7B997-E133-2022 Medicamentos Insabi | 417.6M | 2023-01-01 |
| Aa-012M7B998-E197-2021 Medicamentos Insabi | 249.4M | 2022-01-01 |
| Aa-006000993-E21-2020 Medicamentos | 135.5M | 2020-03-20 |
| Adjudicación Directa Aa-012M7B997-E133-2022 Cons. (Ce-051Gyn007-E66-2022) | 116.0M | 2023-01-01 |
| Adjudicación Directa Aa-006000993-E21-2020 Cons. (Ce-051Gyn007-E27-2020) | 52.1M | 2020-03-24 |
| Adjudicación Directa Aa-012M7B998-E197-2021 Cons. (Ce-051Gyn007-E93-2021) | 40.1M | 2022-01-01 |
| Adjudicación Directa Intern. Consolidada No. Aa-051Gyn007-E30-2019, Medicamentos | 29.7M | 2019-10-03 |
| Ad-Ssa-14-2019 Medicamentos | 29.3M | 2019-08-26 |